Status:
COMPLETED
Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Hepatitis B
Hepatitis, Viral, Human
Eligibility:
All Genders
Up to 3 years
Phase:
PHASE3
Brief Summary
To evaluate whether hepatitis B immune globulin with a high level of antibody against the hepatitis B antigen would be capable of interrupting maternal-fetal transmission of hepatitis B virus, the sin...
Detailed Description
BACKGROUND: A baseline study on the vertical transmission of hepatitis B virus in Taiwan revealed that 15 percent of all pregnant women were persistent carriers of hepatitis B antigen and that 40 per...
Eligibility Criteria
Boy and girl infants, birth to 3 years, born to mothers who were hepatitis B surface antigen carriers.
Key Trial Info
Start Date :
November 1 1975
Trial Type :
INTERVENTIONAL
End Date :
June 1 1986
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000580
Start Date
November 1 1975
End Date
June 1 1986
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.